...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Another IPO that shocks!
4
Jan 13, 2021 02:17PM
3
Jan 13, 2021 03:30PM
4
Jan 16, 2021 08:19AM

narmac - The market doesn't have to make sense. RVX probably had a market cap of about $900 million back 15 years or so ago before they had a clue what they had. 35 million shares at $25 is $875 million. Yes, these companies have been badly mismanaged and the others might or might not do better. The market is tired of RVX and Zenith never fulfilling promises. Only they can change that.

4
Jan 17, 2021 08:27AM
3
Jan 17, 2021 04:05PM
3
Jan 18, 2021 07:35AM
Share
New Message
Please login to post a reply